References
- Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415-537. DOI: 10.1093/eurheartj/ehae177
- AlShaikh S, Rohm CL, Sutton NR, Burgess SN, Alasnag M. INOCA: Ischemia in non-obstructive coronary arteries. American Heart Journal Plus: Cardiol Res Pract. 2024;42:100391. DOI: 10.1016/j. ahjo.2024.100391
- Jespersen L, Hvelplund A, Abildstrøm SZ, Pedersen F, Galatius S, Madsen JK, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012;33(6):734-44. DOI: 10.1093/eurheartj/ehr331
- Pepine CJ, Anderson RD, Sharaf BL, Reis SE, Smith KM, Handberg EM, et al. Coronary Microvascular Reactivity to Adenosine Predicts Adverse Outcome in Women Evaluated for Suspected Ischemia. Results From the National Heart, Lung and Blood Institute WISE (Women’s Ischemia Syndrome Evaluation) Study. J Am Coll Cardiol. 2010;55(25):2825-32. DOI: 10.1016/j.jacc.2010.01.054
- Noel Bairey Merz C, Pepine CJ, Walsh MN, Fleg JL. Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade. Circulation. 2017;135(11):1075-92. DOI: 10.1161/CIRCULATIONAHA.116.024534
- Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, Handberg EM, et al. Adverse Cardiovascular Outcomes in Women With Nonobstructive Coronary Artery Disease: A Report From the Women’s Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med. 2009;169(9):843-50. DOI: 10.1001/archinternmed.2009.50
- Tona F, Serra R, Di Ascenzo L, Osto E, Scarda A, Fabris R, et al. Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease. Nutrit Metabol Cardiovasc Dis. 2014;24(4):447-53. DOI: 10.1016/j.numecd.2013.09.021
- Taube A, Schlich R, Sell H, Eckardt K, Eckel J. Inflammation and metabolic dysfunction: links to cardiovascular diseases. Am J Physiol Heart Circ Physiol. 2012;302(11):H2148-65. DOI: 10.1152/ajpheart.00907.2011
- Wei X, Zhang Z, Wei J, Luo C. Association of systemic immune inflammation index and system inflammation response index with clinical risk of acute myocardial infarction. Front Cardiovasc Med. 2023;10:1248655. DOI: 10.3389/fcvm.2023.1248655
- Li W, Hou M, Ding Z, Liu X, Shao Y, Li X. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Stroke: A Systematic Review and Meta-Analysis. Front Neurol. 2021;12:686983. DOI: 10.3389/fneur.2021.686983
- Delcea C, Buzea CA, Dan GA. The Neutrophil to Lymphocyte Ratio in Heart Failure: A Comprehensive Review. Rom J Intern Med. 2019;57:296-314. DOI: 10.2478/rjim-2019-0018
- Delcea C, Buzea CA, Vîjan AE, Bădilă E, Dan GA. The platelet to lymphocyte ratio in heart failure: a comprehensive review. Rom J Intern Med. 2023;61:84-97. DOI: 10.2478/rjim-2023-0006
- Chen Y, Jiang D, Tao H, Ge P, Duan Q. Neutrophils to high-density lipoprotein cholesterol ratio as a new prognostic marker in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a retrospective study. BMC Cardiovasc Disord. 2022;22:434. DOI: 10.1186/s12872-022-02870-9
- Orfanu A, Popescu C, Tilişcan C, Streinu-Cercel A, Aramă V, Aramă ŞS. The usefulness of neutrophil/lymphocyte count ratio in the diagnosis and prognosis of bacterial sepsis - An old parameter with new implications. Rev Rom Med Lab. 2020;28:39-48. DOI: 10.2478/rrlm-2020-0002
- Molnar C, Molnar C, Nicolescu CL, Botoncea M, Butiurca VO, Suciu BA, et al. The predictive role of platelet to lymphocyte ratio in the occurrence of anastomotic complications following gastric resections for neoplasia - single centre experience. Rev Rom Med Lab. 2020;28:185-94. DOI: 10.2478/rrlm-2020-0011
- Mihai DE, Delcea C, Buzea CA, Balan S, Dan GA. Coronary artery tortuosity and mid-term all-cause mortality of patients with ischemia and non-obstructive coronary arteries. Rom J Intern Med. 2023;61:202-11. DOI: 10.2478/rjim-2023-0019
- Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;184:E368-454. DOI: 10.1161/CIR.0000000000001029
- Delcea C, Buzea CA, Vijan A, Draghici A, Stoichitoiu LE, Dan GA, et al. Comparative role of hematological indices for the assessment of in-hospital outcome of heart failure patients. Scandinav Cardiovasc J. 2021;55:227-36 DOI: 10.1080/14017431.2021.1900595
- Delcea C, Adrian Buzea C, Dobrev D, Andrei Dan G. Prognostic roles of neutrophil-lymphocyte, monocyte-lymphocyte and platelet-lymphocyte ratios for long-term all-cause mortality in heart failure. IJC Heart Vasculature. 2024;54:101502. DOI: 10.1016/j.ijcha.2024.101502
- Wu CC, Wu CH, Lee CH, Cheng CI. Association between neutrophil percentage-to-albumin ratio (NPAR), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and long-term mortality in community-dwelling adults with heart failure: evidence from US NHANES 2005-2016. BMC Cardiovasc Disord. 2023;23:312. DOI: 10.1186/s12872-023-03316-6
- Arfsten H, Cho A, Prausmüller S, Spinka G, Novak J, Goliasch G, et al. Inflammation-Based Scores as a Common Tool for Prognostic Assessment in Heart Failure or Cancer. Front Cardiovasc Med. 2021;8:725903. DOI: 10.3389/fcvm.2021.725903
- de Liyis BG, Ciaves AF, Intizam MH, Jusuf PJ, Artha IJMR. Hematological biomarkers of troponin, neutrophil-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio serve as effective predictive indicators of high-risk mortality in acute coronary syndrome. BioMedicine (Taiwan). 2023;13(4):31-43. DOI: 10.37796/2211-8039.1425
- Gao X, Liu Y, Tian Y, Rao C, Shi F, Bu H, et al. Prognostic value of peripheral blood inflammatory cell subsets in patients with acute coronary syndrome undergoing percutaneous coronary intervention. J Internat Med Res. 2021; 49:3000605211010059. DOI: 10.1177/03000605211010059
- Wang H, Li S, Yu J, Xu J, Xu Y. Role of leukocyte parameters in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with high thrombus burden. Front Cardiovasc Med. 2024;11:1-7. DOI: 10.3389/fcvm.2024.1397701
- Angkananard T, Anothaisintawee T, McEvoy M, Attia J, Thakkinstian A. Neutrophil Lymphocyte Ratio and Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis. Biomed Res Int. 2018;2018:2703518. DOI: 10.1155/2018/2703518
- Mehta PK, Huang J, Levit RD, Malas W, Waheed N, Merz CNB. Ischemia and No Obstructive Coronary Arteries (INOCA): A narrative review. Atherosclerosis. 2023;363:8-21. DOI: 10.1016/j. atherosclerosis.2022.11.009
- Zhao Y, Ghaedi A, Azami P, Nabipoorashrafi SA, Drissi HB, Dezfouli MA, et al. Inflammatory biomarkers in cardiac syndrome X: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2024;24:276. DOI: 10.1186/s12872-024-03939-3
- Albadri A, Lai K, Wei J, Landes S, Mehta PK, Li Q, et al. Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE). PLoS One. 2017;12:e0177684. DOI: 10.1371/journal.pone.0177684
- Mohammed AA, Liu L, Mareai RM, Mohammed AQ, Yin G, Singh S, et al. Combination of White Blood Cell Count to Mean Platelet Volume Ratio and Neutrophil-To-Platelet Ratio Predicts Long-Term Adverse Events in Patients with MINOCA. Mediators Inflamm. 2022;2022:5642406. DOI: 10.1155/2022/5642406
- Agarwal R, Aurora RG, Siswanto BB, Muliawan HS. The prognostic value of neutrophil-to-lymphocyte ratio across all stages of coronary artery disease. Coron Artery Dis. 2022;33:137-43. DOI: 10.1097/MCA.0000000000001040
- Gürdal A, Keskin K, Siğirci S, Yildiz SS, Kiliçkesmez KO. Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients With Myocardial Infarction With Non-obstructive Coronary Arteries. Angiology. 2020;71:812-6. DOI: 10.1177/0003319720938621
- Fan Z, Ji H, Li Y, Jian X, Li L, Liu T. Relationship between monocyteto-lymphocyte ratio and coronary plaque vulnerability in patients with stable angina. Biomark Med. 2017;11:979-90. DOI: 10.2217/bmm-2017-0235
- Vakhshoori M, Nemati S, Sabouhi S, Shakarami M, Yavari B, Emami SA, et al. Prognostic impact of monocyte-to-lymphocyte ratio in coronary heart disease: a systematic review and meta-analysis. J Internat Med Res. 2023;51(10):3000605231204469. DOI: 10.1177/03000605231204469
- Wang QC, Wang ZY. Comparative analysis of neutrophilto-lymphocyte ratio and remnant cholesterol in predicting cardiovascular events and mortality in general adult population. Sci Rep. 2023;13:22362. DOI: 10.1038/s41598-023-49403-8
- Hua Y, Sun JY, Lou YX, Sun W, Kong XQ. Monocyte-to-lymphocyte ratio predicts mortality and cardiovascular mortality in the general population. Int J Cardiol. 2023;379:118-26. DOI: 10.1016/j.ijcard.2023.03.016
- Song M, Graubard BI, Rabkin CS, Engels EA. Neutrophil-tolymphocyte ratio and mortality in the United States general population. Sci Rep. 2021;11:464. DOI: 10.1038/s41598-020-79431-7
- Fest J, Ruiter TR, Groot Koerkamp B, Rizopoulos D, Ikram MA, van Eijck CHJ, Stricker BH. The neutrophil-to-lymphocyte ratio is associated with mortality in the general population: The Rotterdam Study. Eur J Epidemiol. 2019 May;34(5):463-470. DOI: 10.1007/s10654-018-0472-y
- Pruc M, Kubica J, Banach M, Swieczkowski D, Rafique Z, Peacock WF, et al. Diagnostic and prognostic performance of the neutrophil--to-lymphocyte ratio in acute coronary syndromes: A meta-analysis of 90 studies including 45 990 patients. Kardiol Pol. 2024;82:276-84. DOI: 10.33963/v.phj.99554